Literature DB >> 9099955

Induction of the oxidative catabolism of retinoid acid in MCF-7 cells.

M D Krekels1, A Verhoeven, J van Dun, W Cools, C Van Hove, L Dillen, M C Coene, W Wouters.   

Abstract

Cytochrome P450-dependent oxidation is a pathway for all-trans-retinoic acid (all-trans-RA) catabolism. Induction of this catabolic pathway was studied in MCF-7 breast cancer cells. MCF-7 cells showed low constitutive all-trans-RA catabolism. Concentration-dependent induction was obtained by preincubation of the cells with all-trans-RA (10(-9) to 10(-6) M). Onset of induction was fast, being detectable within 60 min, with maximal induction (45-fold) obtained after 16 h. Enzymatic characterization of induced all-trans-RA catabolism showed an estimated Km value (Michaelis-Menten constant) of 0.33 microM and a Vmax value (maximal velocity of an enzyme-catalysed reaction) of 54.5 fmol polar all-trans-RA metabolites 10(6) cells(-1) h(-1). These kinetic parameters represent the overall formation of polar metabolites from all-trans-RA. Induction of all-trans-RA catabolism was also obtained with other retinoids, CH55 >> 13-cis-RA = all-trans-RA > 9-cis-RA > 4-keto-all-trans-RA > 4-keto-13-cis-RA > retinol. The potency of the retinoids to induce all-trans-RA catabolism was correlated to their retinoic acid receptor affinity (Crettaz et al, 1990; Repa et al, 1990; Sani et al, 1990). Induction of all-trans-RA catabolism was inhibited by actinomycin D. Furthermore, all-trans-RA did not increase cytosolic retinoic acid-binding protein (CRABP) mRNA levels. These data suggest that induction of all-trans-RA catabolism in MCF-7 cells is a retinoic acid receptor-mediated gene transcriptional event. Induced all-trans-RA catabolism was inhibited by various retinoids with decreasing potency in the order: all-trans-RA > 4-keto-all-trans-RA > 13-cis-RA > 9-cis-RA > 4-keto-13-cis-RA > retinol > CH55. The antitumoral compound liarozole-fumarate inhibited all-trans-RA catabolism with a potency similar to that of all-trans-RA.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9099955      PMCID: PMC2222791          DOI: 10.1038/bjc.1997.190

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  59 in total

1.  Ketoconazole inhibits the in vitro and in vivo metabolism of all-trans-retinoic acid.

Authors:  J P Van Wauwe; M C Coene; J Goossens; G Van Nijen; W Cools; W Lauwers
Journal:  J Pharmacol Exp Ther       Date:  1988-05       Impact factor: 4.030

2.  Nuclear receptor that identifies a novel retinoic acid response pathway.

Authors:  D J Mangelsdorf; E S Ong; J A Dyck; R M Evans
Journal:  Nature       Date:  1990-05-17       Impact factor: 49.962

3.  Plasma pharmacokinetics and metabolism of 13-cis- and all-trans-retinoic acid in the cynomolgus monkey and the identification of 13-cis- and all-trans-retinoyl-beta-glucuronides. A comparison to one human case study with isotretinoin.

Authors:  J C Kraft; W Slikker; J R Bailey; L G Roberts; B Fischer; W Wittfoht; H Nau
Journal:  Drug Metab Dispos       Date:  1991 Mar-Apr       Impact factor: 3.922

4.  Isolation, partial purification and characterization of nuclear retinoic acid receptors from chick skin.

Authors:  B P Sani; R K Singh; L G Reddy; M P Gaub
Journal:  Arch Biochem Biophys       Date:  1990-11-15       Impact factor: 4.013

5.  Ligand specificities of recombinant retinoic acid receptors RAR alpha and RAR beta.

Authors:  M Crettaz; A Baron; G Siegenthaler; W Hunziker
Journal:  Biochem J       Date:  1990-12-01       Impact factor: 3.857

6.  A third human retinoic acid receptor, hRAR-gamma.

Authors:  A Krust; P Kastner; M Petkovich; A Zelent; P Chambon
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

7.  Expression of cellular retinoic acid binding protein (CRABP) in Escherichia coli. Characterization and evidence that holo-CRABP is a substrate in retinoic acid metabolism.

Authors:  P D Fiorella; J L Napoli
Journal:  J Biol Chem       Date:  1991-09-05       Impact factor: 5.157

8.  Effects of cytochrome P-450 inhibitors on the in vivo metabolism of all-trans-retinoic acid in rats.

Authors:  J P Van Wauwe; M C Coene; J Goossens; W Cools; J Monbaliu
Journal:  J Pharmacol Exp Ther       Date:  1990-01       Impact factor: 4.030

9.  Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: implications for relapse and retinoid "resistance" in patients with acute promyelocytic leukemia.

Authors:  J Muindi; S R Frankel; W H Miller; A Jakubowski; D A Scheinberg; C W Young; E Dmitrovsky; R P Warrell
Journal:  Blood       Date:  1992-01-15       Impact factor: 22.113

10.  Identification of a second human retinoic acid receptor.

Authors:  N Brand; M Petkovich; A Krust; P Chambon; H de Thé; A Marchio; P Tiollais; A Dejean
Journal:  Nature       Date:  1988-04-28       Impact factor: 49.962

View more
  6 in total

1.  First chemical feature-based pharmacophore modeling of potent retinoidal retinoic acid metabolism blocking agents (RAMBAs): identification of novel RAMBA scaffolds.

Authors:  Puranik Purushottamachar; Jyoti B Patel; Lalji K Gediya; Omoshile O Clement; Vincent C O Njar
Journal:  Eur J Med Chem       Date:  2011-11-17       Impact factor: 6.514

Review 2.  Therapeutic potential of the inhibition of the retinoic acid hydroxylases CYP26A1 and CYP26B1 by xenobiotics.

Authors:  Cara H Nelson; Brian R Buttrick; Nina Isoherranen
Journal:  Curr Top Med Chem       Date:  2013       Impact factor: 3.295

3.  The antiproliferative activity of all-trans-retinoic acid catabolites and isomers is differentially modulated by liarozole-fumarate in MCF-7 human breast cancer cells.

Authors:  J Van heusden; W Wouters; F C Ramaekers; M D Krekels; L Dillen; M Borgers; G Smets
Journal:  Br J Cancer       Date:  1998-04       Impact factor: 7.640

4.  All-trans-retinoic acid metabolites significantly inhibit the proliferation of MCF-7 human breast cancer cells in vitro.

Authors:  J Van heusden; W Wouters; F C Ramaekers; M D Krekels; L Dillen; M Borgers; G Smets
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

5.  Inhibition of all-TRANS-retinoic acid metabolism by R116010 induces antitumour activity.

Authors:  J Van Heusden; R Van Ginckel; H Bruwiere; P Moelans; B Janssen; W Floren; B J van der Leede; J van Dun; G Sanz; M Venet; L Dillen; C Van Hove; G Willemsens; M Janicot; W Wouters
Journal:  Br J Cancer       Date:  2002-02-12       Impact factor: 7.640

Review 6.  Are gene expression microarray analyses reliable? A review of studies of retinoic acid responsive genes.

Authors:  Peter J van der Spek; Andreas Kremer; Lynn Murry; Michael G Walker
Journal:  Genomics Proteomics Bioinformatics       Date:  2003-02       Impact factor: 7.691

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.